#42 – The Level is in the Details: Beta-lactam Therapeutic Drug Monitoring
Breakpoints
00:00
The Safety Concerns With Escalating Doses
I see significant variability in concentrations, particularly in our CF burn and trauma patients. This just highlights that relying on a serum creatinine as a surrogate for renal function is not always appropriate. Mark, talk about where this four times the MIC target came from first. And then I'm sure Jason later will be talking about his many trials, Dolly, Blaine, Bliss. So get ready over there.
Transcript
Play full episode
